Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, August 19 at 2:00 PM EDT

Register Free →

Operational Qualification / Performance Verification (OQ/PV) Services

Active
Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

This contract outlines the provision of Operational Qualification and Performance Verification (OQ/PV) services for Agilent Gas Chromatography (GC) systems following maintenance or repair activities. The objective is to verify that the instruments meet the manufacturer's technical specifications and comply with stringent regulatory standards required by FDA-regulated laboratories. The scope includes the execution of standardized testing protocols, accurate collection and documentation of performance data, and the generation of comprehensive final reports that demonstrate system compliance and readiness for use in regulated environments. All testing must be conducted with rigor to ensure data integrity, instrument accuracy, and alignment with federal laboratory requirements. The contract is issued under NAICS code 541380, categorizing it as a scientific and technical consulting service, and is structured as a subcontract within the Department of Health and Human Services framework administered by the FDA Office of Acquisition and Grant Services. The place of performance is specified as 30310, indicating the work is tied to a specific facility or region, though exact location details are not provided. The solicitation was posted August 5, 2026, with responses due by August 19, 2026, setting a clear timeline for interested parties to submit proposals. While no set-aside status or point of contact details are listed, the contractual requirement emphasizes regulatory adherence, precise documentation, and technical expertise to support the continued reliability of analytical instrumentation in critical testing environments.

General Info

OQ/PV services for Agilent GC systems to ensure FDA-compliant performance after maintenance.

Agency

Department Of Health And Human Services → FDA Office Of Acq Grant SvcsView Agency

NAICS

541380 - Testing Laboratories and ServicesView NAICS

Place of Performance

GA, 30310, USA

Set-Aside

NONE

Documents

(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

Posted

subcontract

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → FDA Office Of Acq Grant Svcs
ContactsNo contacts available
OfficeN/A
Organization / Agency
Department Of Health And Human Services → FDA Office Of Acq Grant Svcs
View Agency Profile
Office AddressN/A
ContactsNo contact information available

Full Description

Show more
Formal OQ/PV testing for Agilent GC systems post-maintenance or repair to ensure compliance with manufacturer and FDA laboratory standards, including test execution, data collection, and report generation.

Similar Contracts

Same NAICS industry code

NAICS: 541380
New
International
Infrastructure - Invitation to Bid - Hazardous Building Materials Assessments & Hazardous Building Materials Management Plan Development – North Area Buildings
Solicitation # AB-2026-05519
BGIS has been engaged by Alberta Infrastructure to conduct hazardous building materials assessments and develop hazardous building materials management plans for buildings in the North Area. The work involves identifying, evaluating, and documenting the presence of hazardous materials such as asbestos, lead-based paint, radon, and other regulated substances across a portfolio of provincial facilities. The contractor is responsible for performing site inspections, collecting and analyzing samples, preparing detailed reports, and creating comprehensive management plans that outline mitigation strategies, removal protocols, and long-term monitoring procedures in compliance with provincial regulations and safety standards. The project requires coordination with facility stakeholders and adherence to strict health and safety protocols during all phases of assessment and planning. The solicitation for this contract was issued under reference number AB-2026-05519 and was posted on August 5, 2026, with a response deadline of August 19, 2026. Primary point of contact for inquiries is Jess Pylypow, Facility Manager, reachable via email. The scope of work applies exclusively to buildings located within the North Area of Alberta, and the contractor must demonstrate technical expertise in hazardous materials assessment, regulatory compliance, and project documentation. All deliverables must align with Alberta’s environmental and occupational health requirements, and the successful bidder will be expected to provide timely, accurate, and actionable data to support infrastructure decision-making and public safety.
Infrastructure

POSTED

about 20 hours ago

DEADLINE

in 13 days
View Details
NAICS: 541380
New
DIBBS
Quality Inspection and Compliance TestingThis contract requires third-party inspection and testing of manufactured brackets to ensure full compliance with ISO 9001 quality management standards, MIL-STD-105 sampling procedures for acceptance quality limits, and Defense Logistics Agency quality requirements. The work is focused on verifying dimensional accuracy, material integrity, and process consistency of brackets produced for military applications, with results documented and submitted to confirm adherence to specified technical and quality benchmarks. The inspection activities must be conducted by an accredited independent laboratory or service provider with demonstrated expertise in defense supply chain compliance. The contract is classified as a subcontract under NAICS code 541380, associated with engineering services, and is managed by the Department of Defense through its Land Supply Chain organization. Performance is required at the designated location in Anniston, Alabama, with a response deadline of August 17, 2026. Interested parties must submit proposals by the deadline, and all testing protocols must align with current military and international standards without deviation. The contractor is expected to provide detailed reports, audit trails, and corrective action plans where nonconformities are identified, ensuring traceability and accountability throughout the inspection process.
LAND SUPPLY CHAIN

POSTED

about 23 hours ago

DEADLINE

in 11 days
View Details

More opportunities from Department Of Health And Human Services → FDA Office Of Acq Grant Svcs

Same awarding agency

NAICS: 811210
New
Federal
Preventive and unlimited Corrective Repair (Essentialcare or equal) service agreement for a Surface Plasmon Resonance (SPR) Biacore T200 instrument, Base plus two (2) option years
Solicitation # 75F40126Q135706
The contract is a Request for Quote (RFQ) issued by the FDA Office of Acquisition and Grant Services under the Department of Health and Human Services for a preventive and unlimited corrective repair service agreement for a Surface Plasmon Resonance (SPR) Biacore T200 instrument, structured as a base year plus two optional one-year extensions. The solicitation number is 75F40126Q135706, corrected from an earlier typographical error, and all responses must reference this number. The acquisition is conducted on a full and open, unrestricted basis, with no small business set-aside, despite an initial erroneous inclusion of FAR 52.219-6, which has been formally removed by Amendment A00001. The base performance period runs from August 30, 2026, to August 29, 2027, with option years extending through August 29, 2029. All services must be performed on-site at the FDA/CBER/FBR facility in Silver Spring, Maryland, and include emergency repairs, preventive maintenance, and access to OEM software and firmware updates, with a requirement to respond remotely within eight hours and arrive on-site within three business days without additional charges for parts or labor. Technical capability and past performance are the primary evaluation factors, jointly more important than price, which serves as a differentiator only when technical and performance criteria are essentially equal, indicating a trade-off basis for award, not LPTA. Offerors must comply with HHSAR clauses 352.239-78 and 352.239-79, mandating adherence to Section 508 of the Rehabilitation Act and submission of an Accessibility Conformance Report (ACR) using the HHS-provided template to validate ICT accessibility conformance. Deliverables must be free of macros and executable content, and all submissions must be sent electronically via email to Suzanne Martella at FDA by the deadline of August 10, 2026, at 2:00 PM Central Time. Invoices must be submitted electronically through the Treasury’s Invoice Processing Platform (IPP), with payment terms net 30 days after government acceptance. The contract requires a Letter of Commitment for subcontractor or OEM agreements and mandates that any non-conforming deliverables be remediated at the contractor’s expense. The Contracting Officer has sole authority to modify the agreement, with
Electronic and Precision Equipment Repair and Maintenance

POSTED

1 day ago

DEADLINE

in 4 days
View Details
NAICS: 334516
New
Federal
Pulsed Field Ablation (PFA) System for Non-Clinical Research Use
Solicitation # SSN_CDRH-2026-134633
The U.S. Food and Drug Administration is seeking information from vendors capable of providing a complete, off-the-shelf Pulsed Field Ablation (PFA) system intended for non-clinical research use. The required system must include a PFA generator, compatible catheters, all necessary accessories and cables, on-site installation, startup and operational verification, training, comprehensive documentation, warranty coverage, and ongoing technical support. The system must be FDA-approved or cleared for clinical use in the United States to treat atrial fibrillation or other cardiac arrhythmias, ensuring its technological validity and regulatory compliance. This request is solely for market research and does not obligate the government to proceed with a procurement or issue a formal solicitation. Vendors interested in responding must submit the required Vendor Response Form along with supporting documentation demonstrating their capability to meet all specified requirements by the deadline of August 10, 2026, at 2:30 PM Eastern Time. The solicitation number is SSN_CDRH-2026-134633, and the NAICS code is 334516. All responses should be directed to Iris Johnson at the FDA Office of Acquisition and Grant Services in Rockville, Maryland, with contact information provided for email and phone. This sources sought notice is posted on SAM.gov and is part of the FDA’s effort to evaluate available commercial solutions before potential future procurement actions.
Analytical Laboratory Instrument Manufacturing

POSTED

1 day ago

DEADLINE

in 4 days
View Details
NAICS: 611430
New
Federal
Generic Drug Pathway Curriculum: From ANDA Submission to Global Reliance
Solicitation # FDA-OC-2026-135574
The U.S. Food and Drug Administration intends to award a sole-source, firm-fixed-price order to DIA Inc. for the development and delivery of a professional certification program focused on FDA’s generic drug regulation and regulatory reliance practices, targeting regulatory staff from low- and middle-income countries. This action is justified under FAR 6.103-1 due to the unique capability and immediate availability of DIA Inc. to fulfill the requirement, its deep institutional knowledge of FDA’s regulatory framework and global harmonization efforts, and the time-sensitive nature of building regulatory capacity abroad. The contractor must have established relationships with foreign regulatory authorities to enable effective engagement, needs assessment, content validation, and continuous improvement of a competency-based training curriculum aligned with ANSI/IACET standards for Continuing Education Units. The program, titled “Generic Drug Pathway Curriculum: From ANDA Submission to Global Reliance,” will support the Office of Global Policy and Strategy’s mission to strengthen international regulatory systems by equipping NRAs with the technical know-how to assess generic drug applications and adopt reliance models consistent with FDA practices. The task requires specialized expertise in global regulatory convergence, training design for public health professionals, and direct experience working with LMIC regulatory bodies. Performance will be based in Silver Spring, Maryland, with a one-year base period of performance under NAICS code 611430. No competitive solicitation is being issued, as market research confirms that only DIA Inc. possesses the necessary combination of subject matter expertise, global network, and proven track record to execute this mission-critical initiative on the required timeline.
Professional and Management Development Training

POSTED

1 day ago

DEADLINE

in 14 days
View Details